Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,766 | -6,694 | -13,700 | -10,392 | -7,025 |
| Depreciation Amortization | 20 | 9 | 34 | 25 | 16 |
| Other Working Capital | 409 | 336 | -771 | -1,196 | -1,366 |
| Other Operating Activity | 391 | 192 | 880 | 686 | 487 |
| Operating Cash Flow | $-11,946 | $-6,157 | $-13,557 | $-10,877 | $-7,888 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,224 | 16,087 | -18,527 | -20,335 | -18,345 |
| PPE Investments | -2 | -2 | -6 | -3 | -3 |
| Other Investing Activity | -252 | -137 | -357 | -196 | -118 |
| Investing Cash Flow | $22,970 | $15,948 | $-18,890 | $-20,534 | $-18,466 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 33,090 | 33,090 | 33,090 |
| Financing Cash Flow | $N/A | $N/A | $33,090 | $33,090 | $33,090 |
| Beginning Cash Position | 1,779 | 1,779 | 1,136 | 1,136 | 1,136 |
| End Cash Position | 12,803 | 11,570 | 1,779 | 2,815 | 7,872 |
| Net Cash Flow | $11,024 | $9,791 | $643 | $1,679 | $6,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,946 | -6,157 | -13,557 | -10,877 | -7,888 |
| Capital Expenditure | -2 | -2 | -6 | -3 | -3 |
| Free Cash Flow | -11,948 | -6,159 | -13,563 | -10,880 | -7,891 |